Treatment of COVID-19 by CD24FC; a mini-review to the current knowledge Article Swipe
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.34172/jpe.2021.04
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is already known for its respiratory infection, but it involved more organs such as the kidney, liver, and heart. Most of the patients with COVID-19 have mild symptoms, but 5% of cases are admitted to an intensive care unit (ICU) for severe symptoms, including multi-organ failure and septic shock. Excessive immune responses play an essential role in sepsis development and are associated with worse prognosis in COVID-19 patients. Consequently, reduction of these immune responses may be helpful for managing COVID-19 patients. In this mini-review, we discuss the prospective role of CD24FC, as a recombinant protein with immunomodulatory function, in the treatment of COVID-19 patients and its mechanism of action in the regulation of the immune system.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.34172/jpe.2021.04
- https://jprevepi.com/PDF/jpe-6-e04.pdf
- OA Status
- diamond
- Cited By
- 2
- References
- 22
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3200041652
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3200041652Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.34172/jpe.2021.04Digital Object Identifier
- Title
-
Treatment of COVID-19 by CD24FC; a mini-review to the current knowledgeWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-06-19Full publication date if available
- Authors
-
Ghazal Ghasempour Dabaghi, Mehrdad Rabiee Rad, Lillian SaberianList of authors in order
- Landing page
-
https://doi.org/10.34172/jpe.2021.04Publisher landing page
- PDF URL
-
https://jprevepi.com/PDF/jpe-6-e04.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://jprevepi.com/PDF/jpe-6-e04.pdfDirect OA link when available
- Concepts
-
Medicine, Immune system, Septic shock, Intensive care unit, Coronavirus disease 2019 (COVID-19), Intensive care medicine, Sepsis, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus, Intensive care, Respiratory system, Immunology, Internal medicine, Disease, Infectious disease (medical specialty)Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 1, 2022: 1Per-year citation counts (last 5 years)
- References (count)
-
22Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3200041652 |
|---|---|
| doi | https://doi.org/10.34172/jpe.2021.04 |
| ids.doi | https://doi.org/10.34172/jpe.2021.04 |
| ids.mag | 3200041652 |
| ids.openalex | https://openalex.org/W3200041652 |
| fwci | 0.1462874 |
| type | article |
| title | Treatment of COVID-19 by CD24FC; a mini-review to the current knowledge |
| biblio.issue | 1 |
| biblio.volume | 6 |
| biblio.last_page | e04 |
| biblio.first_page | e04 |
| topics[0].id | https://openalex.org/T10041 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9988999962806702 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | COVID-19 Clinical Research Studies |
| topics[1].id | https://openalex.org/T10118 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9983000159263611 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[2].id | https://openalex.org/T10218 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9886000156402588 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Sepsis Diagnosis and Treatment |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.785915732383728 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C8891405 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7295609712600708 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[1].display_name | Immune system |
| concepts[2].id | https://openalex.org/C2777628635 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6998170614242554 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1765564 |
| concepts[2].display_name | Septic shock |
| concepts[3].id | https://openalex.org/C2776376669 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6527707576751709 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q5094647 |
| concepts[3].display_name | Intensive care unit |
| concepts[4].id | https://openalex.org/C3008058167 |
| concepts[4].level | 4 |
| concepts[4].score | 0.6193939447402954 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[4].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[5].id | https://openalex.org/C177713679 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5925524234771729 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[5].display_name | Intensive care medicine |
| concepts[6].id | https://openalex.org/C2778384902 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5473419427871704 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q183134 |
| concepts[6].display_name | Sepsis |
| concepts[7].id | https://openalex.org/C3007834351 |
| concepts[7].level | 5 |
| concepts[7].score | 0.4925597310066223 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[7].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[8].id | https://openalex.org/C2777648638 |
| concepts[8].level | 5 |
| concepts[8].score | 0.4792994558811188 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q57751738 |
| concepts[8].display_name | Coronavirus |
| concepts[9].id | https://openalex.org/C2987404301 |
| concepts[9].level | 2 |
| concepts[9].score | 0.43982866406440735 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[9].display_name | Intensive care |
| concepts[10].id | https://openalex.org/C534529494 |
| concepts[10].level | 2 |
| concepts[10].score | 0.43411171436309814 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7891 |
| concepts[10].display_name | Respiratory system |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3131495714187622 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C126322002 |
| concepts[12].level | 1 |
| concepts[12].score | 0.2844587564468384 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[12].display_name | Internal medicine |
| concepts[13].id | https://openalex.org/C2779134260 |
| concepts[13].level | 2 |
| concepts[13].score | 0.1793922483921051 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[13].display_name | Disease |
| concepts[14].id | https://openalex.org/C524204448 |
| concepts[14].level | 3 |
| concepts[14].score | 0.102230966091156 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[14].display_name | Infectious disease (medical specialty) |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.785915732383728 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/immune-system |
| keywords[1].score | 0.7295609712600708 |
| keywords[1].display_name | Immune system |
| keywords[2].id | https://openalex.org/keywords/septic-shock |
| keywords[2].score | 0.6998170614242554 |
| keywords[2].display_name | Septic shock |
| keywords[3].id | https://openalex.org/keywords/intensive-care-unit |
| keywords[3].score | 0.6527707576751709 |
| keywords[3].display_name | Intensive care unit |
| keywords[4].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[4].score | 0.6193939447402954 |
| keywords[4].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[5].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[5].score | 0.5925524234771729 |
| keywords[5].display_name | Intensive care medicine |
| keywords[6].id | https://openalex.org/keywords/sepsis |
| keywords[6].score | 0.5473419427871704 |
| keywords[6].display_name | Sepsis |
| keywords[7].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[7].score | 0.4925597310066223 |
| keywords[7].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[8].id | https://openalex.org/keywords/coronavirus |
| keywords[8].score | 0.4792994558811188 |
| keywords[8].display_name | Coronavirus |
| keywords[9].id | https://openalex.org/keywords/intensive-care |
| keywords[9].score | 0.43982866406440735 |
| keywords[9].display_name | Intensive care |
| keywords[10].id | https://openalex.org/keywords/respiratory-system |
| keywords[10].score | 0.43411171436309814 |
| keywords[10].display_name | Respiratory system |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.3131495714187622 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/internal-medicine |
| keywords[12].score | 0.2844587564468384 |
| keywords[12].display_name | Internal medicine |
| keywords[13].id | https://openalex.org/keywords/disease |
| keywords[13].score | 0.1793922483921051 |
| keywords[13].display_name | Disease |
| keywords[14].id | https://openalex.org/keywords/infectious-disease |
| keywords[14].score | 0.102230966091156 |
| keywords[14].display_name | Infectious disease (medical specialty) |
| language | en |
| locations[0].id | doi:10.34172/jpe.2021.04 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210220719 |
| locations[0].source.issn | 2476-3934 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2476-3934 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of Preventive Epidemiology |
| locations[0].source.host_organization | https://openalex.org/P4310319026 |
| locations[0].source.host_organization_name | Society of Diabetic Nephropathy Prevention |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319026 |
| locations[0].source.host_organization_lineage_names | Society of Diabetic Nephropathy Prevention |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://jprevepi.com/PDF/jpe-6-e04.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Preventive Epidemiology |
| locations[0].landing_page_url | https://doi.org/10.34172/jpe.2021.04 |
| locations[1].id | pmh:oai:doaj.org/article:b83e3ae3ace54c15a19e7ef8f57d6baa |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].license | cc-by-sa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Journal of Preventive Epidemiology, Vol 6, Iss 1, Pp e04-e04 (2021) |
| locations[1].landing_page_url | https://doaj.org/article/b83e3ae3ace54c15a19e7ef8f57d6baa |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5051386011 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9850-874X |
| authorships[0].author.display_name | Ghazal Ghasempour Dabaghi |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4394709146 |
| authorships[0].affiliations[0].raw_affiliation_string | Nickan Research Institute, Isfahan, Iran |
| authorships[0].affiliations[1].raw_affiliation_string | 1, , 2 and , , , |
| authorships[0].institutions[0].id | https://openalex.org/I4394709146 |
| authorships[0].institutions[0].ror | https://ror.org/0313ftn24 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I4394709146 |
| authorships[0].institutions[0].country_code | |
| authorships[0].institutions[0].display_name | Nickan Research Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ghazal Ghasempour Dabaghi |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | 1, , 2 and , , ,, Nickan Research Institute, Isfahan, Iran |
| authorships[1].author.id | https://openalex.org/A5091265165 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6800-6925 |
| authorships[1].author.display_name | Mehrdad Rabiee Rad |
| authorships[1].affiliations[0].raw_affiliation_string | 1, , 2 and , , , |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4394709146 |
| authorships[1].affiliations[1].raw_affiliation_string | Nickan Research Institute, Isfahan, Iran |
| authorships[1].institutions[0].id | https://openalex.org/I4394709146 |
| authorships[1].institutions[0].ror | https://ror.org/0313ftn24 |
| authorships[1].institutions[0].type | nonprofit |
| authorships[1].institutions[0].lineage | https://openalex.org/I4394709146 |
| authorships[1].institutions[0].country_code | |
| authorships[1].institutions[0].display_name | Nickan Research Institute |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mehrdad Rabiee Rad |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | 1, , 2 and , , ,, Nickan Research Institute, Isfahan, Iran |
| authorships[2].author.id | https://openalex.org/A5035721202 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4264-2338 |
| authorships[2].author.display_name | Lillian Saberian |
| authorships[2].affiliations[0].raw_affiliation_string | 1, , 2 and , , , |
| authorships[2].affiliations[1].raw_affiliation_string | Independent Researcher and Author, Toronto, Ontario, Canada |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | Lillian Saberian |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | 1, , 2 and , , ,, Independent Researcher and Author, Toronto, Ontario, Canada |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://jprevepi.com/PDF/jpe-6-e04.pdf |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Treatment of COVID-19 by CD24FC; a mini-review to the current knowledge |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10041 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9988999962806702 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | COVID-19 Clinical Research Studies |
| related_works | https://openalex.org/W2474790959, https://openalex.org/W2057630253, https://openalex.org/W2740671600, https://openalex.org/W2331454882, https://openalex.org/W2274076556, https://openalex.org/W2362037864, https://openalex.org/W1984498786, https://openalex.org/W2280614645, https://openalex.org/W3036062714, https://openalex.org/W2000329364 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2022 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.34172/jpe.2021.04 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210220719 |
| best_oa_location.source.issn | 2476-3934 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2476-3934 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of Preventive Epidemiology |
| best_oa_location.source.host_organization | https://openalex.org/P4310319026 |
| best_oa_location.source.host_organization_name | Society of Diabetic Nephropathy Prevention |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319026 |
| best_oa_location.source.host_organization_lineage_names | Society of Diabetic Nephropathy Prevention |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://jprevepi.com/PDF/jpe-6-e04.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Preventive Epidemiology |
| best_oa_location.landing_page_url | https://doi.org/10.34172/jpe.2021.04 |
| primary_location.id | doi:10.34172/jpe.2021.04 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210220719 |
| primary_location.source.issn | 2476-3934 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2476-3934 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of Preventive Epidemiology |
| primary_location.source.host_organization | https://openalex.org/P4310319026 |
| primary_location.source.host_organization_name | Society of Diabetic Nephropathy Prevention |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319026 |
| primary_location.source.host_organization_lineage_names | Society of Diabetic Nephropathy Prevention |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://jprevepi.com/PDF/jpe-6-e04.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Preventive Epidemiology |
| primary_location.landing_page_url | https://doi.org/10.34172/jpe.2021.04 |
| publication_date | 2021-06-19 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W3012320055, https://openalex.org/W3008090866, https://openalex.org/W3008818676, https://openalex.org/W3091759688, https://openalex.org/W3042021285, https://openalex.org/W2769817004, https://openalex.org/W3129519311, https://openalex.org/W4235924301, https://openalex.org/W2117967934, https://openalex.org/W2810962604, https://openalex.org/W3022903904, https://openalex.org/W2740114337, https://openalex.org/W2023255255, https://openalex.org/W2158924104, https://openalex.org/W1965820060, https://openalex.org/W1874298173, https://openalex.org/W2137701627, https://openalex.org/W2007446460, https://openalex.org/W2098503878, https://openalex.org/W2083160592, https://openalex.org/W2145708130, https://openalex.org/W2092246174 |
| referenced_works_count | 22 |
| abstract_inverted_index.a | 98 |
| abstract_inverted_index.5% | 35 |
| abstract_inverted_index.In | 87 |
| abstract_inverted_index.an | 41, 59 |
| abstract_inverted_index.as | 19, 97 |
| abstract_inverted_index.be | 81 |
| abstract_inverted_index.in | 62, 71, 104, 115 |
| abstract_inverted_index.is | 6 |
| abstract_inverted_index.it | 14 |
| abstract_inverted_index.of | 26, 36, 76, 95, 107, 113, 118 |
| abstract_inverted_index.to | 40 |
| abstract_inverted_index.we | 90 |
| abstract_inverted_index.The | 0 |
| abstract_inverted_index.and | 23, 52, 65, 110 |
| abstract_inverted_index.are | 38, 66 |
| abstract_inverted_index.but | 13, 34 |
| abstract_inverted_index.for | 9, 46, 83 |
| abstract_inverted_index.its | 10, 111 |
| abstract_inverted_index.may | 80 |
| abstract_inverted_index.the | 20, 27, 92, 105, 116, 119 |
| abstract_inverted_index.Most | 25 |
| abstract_inverted_index.care | 43 |
| abstract_inverted_index.have | 31 |
| abstract_inverted_index.mild | 32 |
| abstract_inverted_index.more | 16 |
| abstract_inverted_index.play | 58 |
| abstract_inverted_index.role | 61, 94 |
| abstract_inverted_index.such | 18 |
| abstract_inverted_index.this | 88 |
| abstract_inverted_index.unit | 44 |
| abstract_inverted_index.with | 29, 68, 101 |
| abstract_inverted_index.(ICU) | 45 |
| abstract_inverted_index.acute | 2 |
| abstract_inverted_index.cases | 37 |
| abstract_inverted_index.known | 8 |
| abstract_inverted_index.these | 77 |
| abstract_inverted_index.worse | 69 |
| abstract_inverted_index.action | 114 |
| abstract_inverted_index.heart. | 24 |
| abstract_inverted_index.immune | 56, 78, 120 |
| abstract_inverted_index.liver, | 22 |
| abstract_inverted_index.organs | 17 |
| abstract_inverted_index.sepsis | 63 |
| abstract_inverted_index.septic | 53 |
| abstract_inverted_index.severe | 1, 47 |
| abstract_inverted_index.shock. | 54 |
| abstract_inverted_index.CD24FC, | 96 |
| abstract_inverted_index.already | 7 |
| abstract_inverted_index.discuss | 91 |
| abstract_inverted_index.failure | 51 |
| abstract_inverted_index.helpful | 82 |
| abstract_inverted_index.kidney, | 21 |
| abstract_inverted_index.protein | 100 |
| abstract_inverted_index.system. | 121 |
| abstract_inverted_index.COVID-19 | 30, 72, 85, 108 |
| abstract_inverted_index.admitted | 39 |
| abstract_inverted_index.involved | 15 |
| abstract_inverted_index.managing | 84 |
| abstract_inverted_index.patients | 28, 109 |
| abstract_inverted_index.Excessive | 55 |
| abstract_inverted_index.essential | 60 |
| abstract_inverted_index.function, | 103 |
| abstract_inverted_index.including | 49 |
| abstract_inverted_index.intensive | 42 |
| abstract_inverted_index.mechanism | 112 |
| abstract_inverted_index.patients. | 73, 86 |
| abstract_inverted_index.prognosis | 70 |
| abstract_inverted_index.reduction | 75 |
| abstract_inverted_index.responses | 57, 79 |
| abstract_inverted_index.symptoms, | 33, 48 |
| abstract_inverted_index.treatment | 106 |
| abstract_inverted_index.associated | 67 |
| abstract_inverted_index.infection, | 12 |
| abstract_inverted_index.regulation | 117 |
| abstract_inverted_index.development | 64 |
| abstract_inverted_index.multi-organ | 50 |
| abstract_inverted_index.prospective | 93 |
| abstract_inverted_index.recombinant | 99 |
| abstract_inverted_index.respiratory | 3, 11 |
| abstract_inverted_index.(SARS-CoV-2) | 5 |
| abstract_inverted_index.mini-review, | 89 |
| abstract_inverted_index.Consequently, | 74 |
| abstract_inverted_index.immunomodulatory | 102 |
| abstract_inverted_index.syndrome-coronavirus-2 | 4 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 3 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8799999952316284 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.49317855 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |